focus -WSS

focus

author：fashion 2025-10-01 15:31:09 - browse：365

Pfizer and Moderna aren’t the only vaccine money-makers. Much of the revenue and profits from Covid-19 vaccines are flowing behind the scenes, going to the contract manufacturers and clinical-trial organizers that turn the shots from lab-bench theory to mass-produced reality.

Both AstraZeneca and Johnson & Johnson publicly committed to not profiting off their products during the pandemic — though AstraZeneca has reserved the right to declare the pandemic over on July 1, even if the World Health Organization has not. Pfizer and Moderna made no such pledge, with Pfizer expected to make $15 billion in vaccine-related revenue this year, while Moderna is forecasting $18.4 billion in vaccine sales.

Contractors hired to test and manufacture these vaccines have enjoyed a share of the profits without the same level of public scrutiny.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Intellia reports positive results for its CRISPR

WSS

Chicago flooding is stark reminder of vulnerability of major cities during extreme weather

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Russians and Belarusians back at Wimbledon as war in Ukraine continues

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

entertainment

focus

Wikipedia

Apple is now the first public company to be valued at $3 trillion

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Continuity nursing helped my family in our darkest PICU moments

Woman returns to dialysis after doctors remove transplanted pig kidney

As demand for Covid shots wanes, Moderna seeks its next success

Greece's new parliament sworn in following conservative party's election victory

Psychedelics group wrestles with new pharma identity

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

Heart attack and stroke risk calculators need revising

Woman returns to dialysis after doctors remove transplanted pig kidney

knowledge

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Greece's new parliament sworn in following conservative party's election victory

Chicago flooding is stark reminder of vulnerability of major cities during extreme weather

Cord blood banking comes at a high cost to babies

Some in Scotland's Orkney Islands want to return to Norway after 550 years

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

hotspot

knowledge

focus

focus